These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Differentiation and maturation of erythroblasts].
    Author: Nakamura Y.
    Journal: Rinsho Byori; 1998 May; 46(5):435-40. PubMed ID: 9627494.
    Abstract:
    Erythropoietin/receptor (EPO/EPOR) system is a pivotal regulator of erythropoiesis. Indeed, EPO-deficient and EPOR-deficient mice are embryonic lethal. The EPOR has two dominant forms, a full-length one (EPOR-F) and a truncated one (EPOR-T), by an alternative splicing mechanism of mRNA. The EPOR-T expresses abundantly in more immature erythroid progenitor cells. The EPOR-T acts as a dominant negative regulator of EPO-signals for proliferation and anti-apoptosis in cell lines. Presumably, the EPOR-T forms a heterodimer with EPOR-F and results in inhibition of efficient EPO-signals. Transgenic mice over-expressing the EPOR-T show an anemia and a severe defect in recovery from acute anemia. This result strongly suggests that the EPOR-T acts as a negative regulator for erythropoiesis also in vivo. It was reported that a large number of erythroid precursor cells die of apoptosis under physiological concentration of EPO in mouse. At higher EPO-concentration, these erythroid precursors escape from apoptosis and mature into erythrocytes. This mechanism might allow immediate supply of a large number of erythrocytes in case of acute anemia. In such mechanism, the EPOR-T might play an important role as a regulator of EPO-induced signals in erythroid cells.
    [Abstract] [Full Text] [Related] [New Search]